Chemotherapy Dose Reductions and Dose Delays Due to Thrombocytopenia

被引：0
|
作者：
Prakash, Gautham [1 ]
Pandrangi, Kelsey [1 ]
Khateeb, Ranya [1 ]
Jain, Shivi [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
311
引用
收藏
页码：11248 / 11249
页数：2
相关论文
共 50 条
  • [41] Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia
    Robert D Levin
    MaryAnn Daehler
    James F Grutsch
    John L Hall
    Digant Gupta
    Christopher G Lis
    BMC Cancer, 10
  • [42] DOSE INTENSITY IN CHEMOTHERAPY
    TONKIN, K
    TANNOCK, I
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 891 - 891
  • [43] DOSE OF INTRAVESICAL CHEMOTHERAPY
    MASTERS, JRW
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 540 - 540
  • [44] THROMBOCYTOPENIA AND LOW-DOSE HEPARIN
    PHILLIPS, YY
    COPLEY, JB
    STOR, RA
    SOUTHERN MEDICAL JOURNAL, 1983, 76 (04) : 526 - 528
  • [45] Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma
    Murakami, Tetsushi
    Kikuchi, Eiji
    Ide, Hiroki
    Umezawa, Yuta
    Takahashi, Takayuki
    Izawa, Mizuki
    Hakozaki, Kyohei
    Shigeta, Keisuke
    Ogihara, Koichiro
    Kobayashi, Hiroaki
    Kanai, Kunimitsu
    Maeda, Takahiro
    Yoshimine, Shunsuke
    Mizuno, Ryuichi
    Nishimoto, Koshiro
    Oya, Mototsugu
    BJUI COMPASS, 2021, 2 (05): : 322 - 330
  • [46] COMPARING THE IMPACT OF DOSE REDUCTIONS/ DELAYS ON OVARIAN CANCER OUTCOMES USING THREE WEEKLY OR DOSE DENSE CARBOPLATIN/ PACLITAXEL REGIMENS IN THE NATIONAL PROSPECTIVE OPAL COHORT
    Mileshkin, L.
    Sivakumaran, T.
    Grant, P.
    Na, L.
    Friedlander, M.
    Webb, P.
    Au-Yeung, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 770 - 770
  • [47] AMELIORATION OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA BY GM-CSF - APPARENT DOSE AND SCHEDULE DEPENDENCY
    EDMONSON, JH
    LONG, HJ
    JEFFRIES, JA
    BUCKNER, JC
    COLONOTERO, G
    FITCH, TR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (19) : 1510 - 1512
  • [48] Clinical approaches involving thrombopoietin to shorten the period of thrombocytopenia after high-dose chemotherapy
    Tijssen, Marloes R.
    van der Schoot, Ellen
    Voermans, Carlijn
    Zwaginga, Jaap Jan
    TRANSFUSION MEDICINE REVIEWS, 2006, 20 (04) : 283 - 293
  • [49] Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia
    Elting, LS
    Rubenstein, EB
    Martin, CG
    Kurtin, D
    Rodriguez, S
    Laiho, E
    Kanesan, K
    Cantor, SB
    Benjamin, RS
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1137 - 1146
  • [50] PATIENT EXPERIENCE OF DOSE REDUCTIONS OF FABRAZYME(R)
    Cousins, A.
    Fondo, A.
    Murphy, E.
    Lachmann, R.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S157 - S157
12345